success
deal
sar
partial
attribut
detect
uniqu
diseas
within
establish
healthcar
system
intern
effort
contain
spread
diseas
rapid
identif
newli
emerg
pathogen
use
advanc
molecular
techniqu
despit
success
outbreak
expos
sever
weak
establish
surveil
network
demonstr
potenti
social
econom
toll
infecti
diseas
outbreak
exert
even
develop
countri
sar
slowspread
viru
low
communic
long
incub
period
yet
spread
countri
five
contin
period
week
infect
patient
fatal
poon
et
al
contrast
influenza
shorter
incub
period
higher
infecti
rate
sar
annual
kill
ten
thousand
person
global
attent
focus
increas
number
influenza
outbreak
poultri
human
well
increas
infect
human
avian
influenza
virus
wong
yuen
although
clear
evid
effici
humantohuman
transmiss
avian
influenza
yet
report
increas
number
confirm
influenza
famili
cluster
rais
concern
sustain
humantohuman
transmiss
soon
emerg
gilsdorf
et
al
kandun
et
al
sar
epidem
streptococcu
sui
outbreak
china
ye
et
al
current
spread
influenza
around
world
exampl
highlight
need
global
engag
region
diseas
outbreak
especi
resourcepoor
countri
burden
diseas
highest
lopez
et
al
sustain
global
invest
need
improv
capac
mani
develop
countri
detect
endem
epidem
newli
emerg
pathogen
accur
determin
agentspecif
region
diseas
burden
help
guid
alloc
limit
resourc
use
exist
prevent
modal
provid
crucial
inform
vaccin
develop
assist
public
health
author
establish
direct
vaccin
program
public
health
prevent
strategi
sinc
agentspecif
diseas
burden
estim
like
vari
base
region
condit
import
establish
differ
geograph
epidemiolog
profil
order
establish
prioriti
prevent
strategi
public
health
laboratori
phl
form
foundat
global
surveil
network
face
key
dilemma
respect
identif
viral
pathogen
respiratori
sampl
believ
mani
problem
might
address
select
use
newli
avail
commerci
respiratori
viral
panel
rvp
newest
rvp
allow
sensit
specif
detect
viral
pathogen
follow
extens
multiplex
polymeras
chain
reaction
pcr
reversetranscriptas
pcr
rtpcr
reaction
without
loss
sensit
previous
seen
diagnost
system
li
et
al
sar
laboratori
toronto
face
surg
number
respiratori
sampl
time
normal
encount
normal
respiratori
viru
season
phl
also
requir
identifi
wide
varieti
respiratori
virus
ten
thousand
patient
sampl
respiratori
viru
outbreak
well
sporad
case
fever
respiratori
ill
thu
identif
method
must
rapid
comprehens
must
conserv
laboratori
well
human
resourc
brown
cheng
et
al
although
tradit
method
identif
use
combin
method
ie
cultur
rapid
antigen
detect
assay
low
target
number
molecular
assay
often
effect
dunn
et
al
zitterkopf
et
al
combin
techniqu
reduc
number
patient
sampl
test
one
time
also
limit
sampl
volum
avail
test
khanna
et
al
sinc
etiolog
onehalf
threequart
communityacquir
pneumonia
case
unknown
new
technolog
identifi
wider
varieti
respiratori
virus
need
ewig
et
al
fine
et
al
garbino
et
al
initi
difficulti
cultur
emerg
avian
influenza
virus
brown
common
virus
human
metapneumoviru
scheltinga
et
al
indic
phl
must
develop
cultureindepend
diagnost
method
even
though
noncultur
base
method
ie
molecular
diagnost
wide
avail
identif
individu
respiratori
viral
pathogen
method
simultan
screen
wide
array
pathogen
need
rachlin
et
al
past
decad
seen
emerg
sever
new
respiratori
virus
gillimross
subbarao
spectr
agent
includ
pandem
influenza
bioterror
agent
mean
phl
face
increas
pressur
identifi
new
agent
emerg
develop
capac
separ
highli
pathogen
agent
less
virul
season
respiratori
virus
cirino
et
al
extens
multiplex
pcr
reaction
may
help
phl
identifi
wide
varieti
agent
without
use
biosafeti
level
iii
laboratori
molecular
techniqu
also
allow
phl
identifi
subtyp
strain
emerg
respiratori
virus
laboratori
work
group
pandem
influenza
suggest
phl
retain
abil
subtyp
character
influenza
strain
ie
resist
test
virul
test
use
techniqu
propos
dilemma
might
solv
use
broadspectrum
commerci
avail
respiratori
viru
panel
util
extens
multiplex
technolog
proper
plan
rvp
may
integr
protocol
allow
larg
number
sampl
test
rapidli
econom
brunstein
thoma
inclus
difficult
grow
viral
pathogen
panel
provid
better
data
preval
rvp
also
integr
pandem
prepared
bioterror
plan
use
subtyp
influenza
virus
may
use
earli
phase
pandem
differenti
outbreak
caus
season
influenza
pathogen
caus
emerg
pandem
strain
extens
multiplex
natur
newer
rvp
might
allow
develop
new
tool
diagnosi
pathogen
use
biolog
warfar
bioterror
believ
emerg
commerci
avail
respiratori
viru
panel
herald
new
era
public
health
microbiolog
tool
hope
improv
work
flow
also
benefit
clinic
report
public
health
epidemiolog
increas
laboratori
prepared
pandem
influenza
emerg
pathogen
none
declar
dr
brice
would
like
thank
jeanpaul
chretien
shannon
putnam
discuss
review
manuscript
opinion
view
author
constru
offici
view
depart
navi
depart
defens
dr
low
research
support
tm
bioscienc
